Defneu

Description

Defneu Suspension contains Deflazacort, a corticosteroid used under medical supervision to manage certain inflammatory and immune-mediated conditions. It works by reducing inflammation and modifying the body’s immune response. Defneu is supplied in a 30 ml bottle with carton packaging and is listed in the paediatric product segment. Its use in children requires an appropriate diagnosis, carefully determined dosing, and supervision by a qualified healthcare professional.

Therapeutic Segment

Corticosteroids | Anti-inflammatory Range

Uses of Defneu Suspension

Deflazacort may be prescribed by a qualified healthcare professional for certain inflammatory and immune-mediated conditions, depending on the patient’s diagnosis and approved product labeling.

• Management of selected inflammatory conditions.
• Treatment of certain immune-mediated disorders.
• Management of specific conditions for which corticosteroid therapy is indicated.

Defneu should not be used to treat routine coughs, colds, or other minor illnesses unless specifically prescribed for an appropriate medical indication.

Key Features of Defneu Suspension

• Active ingredient: Contains Deflazacort, a corticosteroid.
• Anti-inflammatory action: Helps reduce inflammation in conditions for which corticosteroid therapy is indicated.
• Immune-modulating action: Modifies immune activity under appropriate medical supervision.
• Paediatric formulation: Listed for the paediatric segment, with use determined by the treating healthcare professional.
• Pack presentation: Supplied in a 30 ml bottle with an outer carton.

How Does Defneu Work?

Deflazacort is a glucocorticoid corticosteroid. It acts on glucocorticoid receptors to reduce the production of inflammatory substances and modify immune responses. Its clinical use depends on the specific condition being treated, the patient’s age and weight, and the prescribed regimen.

Possible Side Effects

Potential side effects of corticosteroids may include increased appetite, stomach discomfort, mood changes, sleep disturbances, and changes in blood glucose levels. Longer-term or high-dose treatment can increase the risk of infections, growth effects in children, adrenal suppression, and other complications.

Seek medical advice if unexpected symptoms develop. Do not stop prolonged corticosteroid treatment abruptly unless directed by the treating healthcare professional.

Important Safety Information

• Use Defneu only when prescribed by a qualified healthcare professional.
• Paediatric dosing must be individualized according to the condition, age, weight, and prescribed regimen.
• Inform the prescriber about current medicines, allergies, and existing medical conditions.
• Tell the healthcare professional if the child has an infection or has recently been exposed to chickenpox or measles.
• Long-term treatment may require monitoring of growth, blood pressure, glucose, and other parameters.
• Do not change the dose or stop prolonged treatment without medical advice.
• Keep the medicine out of reach of children.

Dosage and Administration

The dose and duration depend on the diagnosis, the patient’s age and weight, and the prescriber’s instructions. Confirm the product concentration on the approved label before measuring a dose. Follow the supplied instructions for shaking, measuring, and administering the suspension, if applicable.

Storage Instructions

Store Defneu according to the conditions printed on the product label. Keep the bottle tightly closed and out of reach of children. Follow the label’s instructions regarding use after opening.